Edition:
India

Charles River Laboratories Signs Binding Offer To Acquire Citoxlab


Wednesday, 13 Feb 2019 

Feb 13 (Reuters) - Charles River Laboratories International Inc ::CHARLES RIVER LABORATORIES SIGNS BINDING OFFER TO ACQUIRE CITOXLAB.TRANSACTION EXPECTED TO BE ACCRETIVE TO NON-GAAP EPS BY APPROXIMATELY $0.15 IN 2019.DEAL FOR EUR 448 MILLION IN CASH (OR APPROXIMATELY $510 MILLION BASED ON CURRENT EXCHANGE RATES).SIGNED A BINDING OFFER TO ACQUIRE CITOXLAB FOR EUR 448 MILLION IN CASH.PROPOSED ACQUISITION IS EXPECTED TO ADD $115 TO $130 MILLION TO CHARLES RIVER'S 2019 CONSOLIDATED REVENUE.CHARLES RIVER LABORATORIES INTERNATIONAL - PROPOSED DEAL, FEES EXPECTED TO BE FINANCED THROUGH EXISTING REVOLVING CREDIT FACILITY AND CASH.PROPOSED ACQUISITION IS EXPECTED TO ADD APPROXIMATELY $200 MILLION TO 2020 CONSOLIDATED REVENUE.CHARLES RIVER LABORATORIES INTERNATIONAL- DEAL EXPECTED TO BE ACCRETIVE TO NON-GAAP EARNINGS PER SHARE BY ABOUT $0.15 IN 2019 AND AT LEAST $0.35 IN 2020. 

Company Quote

135.14
1.64 +1.23%
18 Apr 2019